BHC Bausch Health Companies Inc. — earnings, filings & institutional moves

Price chart

Daily historical data with per-account defaults

Latest close

$4.68

Period return

-1.97 (-29.62%)

Volume

2.1M

2026-07-20O $4.8 H $4.82 L $4.68 C $4.68MA5 $4.82MA20 $4.86MA60 $5.19MA120 $5.39

6M · 124 barsYahoo Finance · USD2026-01-21 → 2026-07-20

Recent event timeline

Filings, earnings, research, and institutional changes — newest first

View all →

2026. 07. 29.Highin 8 days
다음 실적 발표 예정
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
2026. 04. 28.Low3 months ago
RBC Capital: r Perform
US analyst rating / recommendation change.
2026. 02. 26.LowHOLD5 months ago
Barclays: Equal-Weight
US analyst rating / recommendation change.
2026. 01. 07.LowHOLD7 months ago
Truist Securities: Hold
US analyst rating / recommendation change.
2025. 12. 10.MediumHOLD7 months ago
Barclays: Equal-Weight
US analyst rating / recommendation change.
2025. 05. 03.Lowlast year
RBC Capital: r Perform
US analyst rating / recommendation change.
2025. 03. 31.Mediumlast year
2026년 1분기 실적 발표
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
2025. 02. 07.MediumHOLDlast year
Jefferies: Hold
US analyst rating / recommendation change.
2025. 01. 31.Lowlast year
RBC Capital: r Perform
US analyst rating / recommendation change.
2024. 11. 02.Low2 years ago
RBC Capital: r Perform
US analyst rating / recommendation change.

Recent earnings

Consensus vs. actual, and revenue trend

Earnings tab →

Research actions

Consensus PT $7.5 · 6 analysts

Research tab →

AI Brief (Premium)

Automated summary from public sources · not investment advice

Brief tab →

No AI brief generated yet. You can create one from the Brief tab.

Top institutions (13F)

Ranked by position value

Institutions tab →

Company info

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
HQ: Laval, QC, Canada
Fiscal year end: —
Employees: 20,300
IPO date: —

View details →

Quarter	Date	Time	EPS est.	EPS actual	Surprise	Rev. est.	Rev. actual	Status
—	2026. 07. 29.	After market close (AMC)	$1	—	—	$2.66B	—	Scheduled
FY2026 Q1	2025. 03. 31.	Time TBD	—	$-0.16	—	—	$2.26B	Reported
FY2025 Q3	2024. 09. 30.	Time TBD	—	$-0.38	—	—	$7.07B	Reported
FY2025 Q2	2024. 06. 30.	Time TBD	—	$-0.15	—	—	$4.56B	Reported

Bausch Health Companies Inc.

Price chart

Recent event timeline

Recent earnings

Research actions

Top news

Key stats

Date	Firm	Analyst	Action	Rating change	Price target	Report
2026. 04. 28.	RBC Capital	—	Maintain	Sector Perform → Sector Perform	—	RBC Capital: Sector Perform
2026. 02. 26.	Barclays	—	Maintain	Equal-Weight → Equal-Weight	—	Barclays: Equal-Weight
2026. 01. 07.	Truist Securities	—	Maintain	Hold → Hold	—	Truist Securities: Hold
2025. 12. 10.	Barclays	—	Initiate coverage	— → Equal-Weight	—	Barclays: Equal-Weight
2025. 05. 03.	RBC Capital	—	Maintain	Sector Perform → Sector Perform	—	RBC Capital: Sector Perform
2025. 02. 07.	Jefferies	—	Downgrade	Buy → Hold	—	Jefferies: Buy → Hold